Find your next paid study

Merck Sharp & Dohme LLCNCT07419295

~$50 – $2,100

Actual pay is set by the research site.

Phase 3

A Phase 3, Multicenter, Double-blind, Randomized Controlled Study Evaluating the Efficacy and Safety of Pegloticase Administered by Subcutaneous Injection Compared With Pegloticase Administered by Intravenous Injection, Both Administered Concurrently With Methotrexate Weekly, in Participants With Uncontrolled Gout

The primary objective of this trial is to evaluate the effect of pegloticase 18 mg subcutaneously (SC) every two weeks with methotrexate (MTX) versus peglotica…

Uncontrolled Gout

Squamous Cell CarcinomaHead and Neck Cancer Squamous Cell CarcinomaHead and Neck Cancer

~$50 – $2,250

Actual pay is set by the research site.

AmgenNCT07388498

Phase 2

A Phase 2 Study of Toripalimab in Combination With Cisplatin and Docetaxel (PDT) for Induction Therapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

This research study is being done to assess the safety and tolerability of toripalimab in combination with cisplatin and docetaxel (PDT) induction therapy for …

Massachusetts General HospitalNCT07214987

~$75 – $2,000

Actual pay is set by the research site.

Phase 2

A Double-blind, Randomized, Placebo-controlled Proof oF Concept Clinical Study to Evaluate the Safety, Pharmacokinetics, AND Pharmacodynamics of Vaginal AZU-101 (Lasofoxifene Tartrate) in Postmenopausal Women

Study Objectives: Primary: • To assess the safety, tolerability, and systemic pharmacokinetics (PK) of AZU-101 Secondary: • To evaluate efficacy of daily v…

Vulvo Vaginal Atrophy (VVA)

Azure Biotech Inc.NCT06197568

~$75 – $2,800

Actual pay is set by the research site.

Phase 3

A Phase 3, Randomized, Placebo-Controlled Study of Adjuvant Intismeran Autogene Plus Subcutaneous Pembrolizumab and Berahyaluronidase Alfa (MK-3475A) or Intismeran Autogene Monotherapy Versus Placebo in Participants With Completely Resected High-Risk Stage I Non-Small Cell Lung Cancer (INTerpath-014)

Researchers are looking for new ways to treat high-risk, localized non-small cell lung cancer (NSCLC) that has been removed with surgery. People with high-ris…

Non-small Cell Lung Cancer

Merck Sharp & Dohme LLCNCT07513376

~$50 – $2,100

Actual pay is set by the research site.

Intrauterine Device Placement

Effect of Periumbilical Vibration on Pain Perception During Intrauterine Device Insertion: A Randomized Controlled Trial

The goal of this randomized controlled trial is to learn if placing a vibrating device at the umbilicus during insertion of intrauterine device (IUD) decreases…

Duke UniversityNCT07714590

Actual pay is set by the research site.

The AC/DCP Trial: Assessment of Closure, Dehiscence, and Aesthetics in Cerebral Palsy Multilevel Surgery. A Randomized, Double-Blinded, Split-Body Trial of Knotless Tissue Control Devices Versus Conventional Suture

This study compares two standard ways of closing surgical incisions in children and adults with cerebral palsy who are having multilevel surgery on both legs (…

Cerebral Palsy

University of California, Los AngelesNCT07880197

Actual pay is set by the research site.

Phase 1

A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision

This study is investigating the effects on immune cells of injecting the influenza vaccine (also known as "flu shot") into cutaneous squamous cell carcinoma (C…

Skin CancerCutaneous Squamous Cell Carcinoma (CSCC)Cutaneous Squamous Cell Cancer

Dana-Farber Cancer InstituteNCT06664151

~$150 – $4,500

Actual pay is set by the research site.

Phase 1

RESET-MG: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Participants With Generalized Myasthenia Gravis

RESET-MG: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Participants with Generalized Myasthenia Gravis

Generalized Myasthenia Gravis (gMG)

Metastatic CancersFatigue

~$150 – $4,500

Actual pay is set by the research site.

Cabaletta BioNCT06359041

Phase 2

Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers

To find out if combining psychoeducational interventions (such as education, counseling, and self-managed therapies) with an open-label placebo can help to imp…

M.D. Anderson Cancer CenterNCT06085716

~$75 – $2,000

Actual pay is set by the research site.

Intubating Conditions Based On The Ratio Between The Twitch Amplitude And Reference Twitch Amplitude: A Randomized, Prospective, Clinical Trial

The purpose of this study is to determine the maximum ratio of the twitch amplitude (T1) to the reference twitch (Tref) amplitude (T1/Tref) that provides excel…

Intubation

Actual pay is set by the research site.

Mayo ClinicNCT07483164

Bladder CarcinomaGenitourinary System NeoplasmKidney Carcinoma+1 more

Assessing Efficacy of a Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

This clinical trial evaluates light therapy and occupational therapy in improving cancer related fatigue (CRF) patients with genitourinary cancers. Light thera…